BillionToOne: The Guidance Looks Conservative, The Price Does Not
BillionToOne Inc BLLN
$138.60
▼ -0.71%
($-0.99)
📅 Earnings This Week
Open
$140.21
Prev Close
$139.59
Day Range
$134.73 – $140.21
52W Range
$61.96 – $140.00
Market Cap
$6.37B
P/E (TTM)
252.54
Beta
1.01
EPS (TTM)
$0.52
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2025-11-06 |
| Shares Out. | 46,000,000 |
| Website | billiontoone.com/ ↗ |
| Phone | 13025310855 |
| Employees | 713 |
| Revenue | $108.4M |
| Gross Profit | $79.1M |
| Net Income | $18.0M |
| Total Assets | $700.7M |
| Total Liabilities | $195.1M |
| Equity | $505.6M |
About BillionToOne Inc
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
BillionToOne Inc is a publicly traded company under the ticker symbol BLLN on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-07-01)